Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis

Arq Bras Cardiol. 2006 Nov;87(5):e222-6. doi: 10.1590/s0066-782x2006001800035.

[Article in English, Portuguese]

Authors

Marcelo Pereira da Rosa¹, Gislaine Verginia Baroni, Vera Lúcia Portal

Affiliation

¹ Instituto de Cardiologia do Rio Grande do Sul, FUC, Porto Alegre, RS, Brazil.

PMID: 17396201
DOI: 10.1590/s0066-782x2006001800035

No abstract available

Publication types

Review

MeSH terms

3',5'-Cyclic-AMP Phosphodiesterases / antagonists & inhibitors*
Atherosclerosis / drug therapy*
Cilostazol
Cyclic Nucleotide Phosphodiesterases, Type 3
Humans
Phosphodiesterase Inhibitors / therapeutic use*
Tetrazoles / therapeutic use*

Substances

Phosphodiesterase Inhibitors
Tetrazoles
3',5'-Cyclic-AMP Phosphodiesterases
Cyclic Nucleotide Phosphodiesterases, Type 3
Cilostazol